Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 13, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining […]
OrthoPediatrics Corp. Reports Preliminary Unaudited Revenue for Fourth Quarter and Record Setting Full Year 2019
WARSAW, Ind., Jan. 13, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the […]
Rubius Therapeutics Announces 2020 Objectives and Provides Operational Update at the 38th Annual J.P. Morgan Healthcare Conference
RTX-240 Investigational New Drug Application for Cancer on File with U.S. Food and Drug AdministrationRubius Manufacturing Facility Operational Nine Months […]
NMI Holdings, Inc. to Announce Fourth Quarter 2019 Financial Results on February 11, 2020
EMERYVILLE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — NMI Holdings, Inc., (NASDAQ: NMIH), the parent company of National Mortgage Insurance […]
Ameri Holdings to Merge with Jay Pharma Inc., Evidence-Based Cannabinoid Medicine & Wellness Company Focused on Cancer
Jay Pharma holds exclusive license with Tikun Olam for cannabinoid intellectual property, including data and genetics for cancer patient careJay […]
electroCore Provides Business Update and Select Financial Guidance
BASKING RIDGE, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an […]
ManTech to Participate in the Cowen 41st Annual Aerospace/Defense & Industrials Conference
HERNDON, Va., Jan. 13, 2020 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT), a leading provider of innovative technologies and solutions for […]
Neos Therapeutics Initiates and Completes Dosing in a Phase 1 Trial of NT0502 for the Treatment of Chronic Sialorrhea
DALLAS and FORT WORTH, Texas, Jan. 13, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical company developing […]
Tetra Bio-Pharma Receives Favorable Letter of Advice from USA FDA for QIXLEEF
FDA Feedback continues to support the development of QIXLEEF for second- or third-line therapy for adult patients with uncontrolled painFDA […]
Ackroo Announces 2019 Revenue Growth Results
HAMILTON, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR), (OTC: AKRFF), a loyalty marketing, gift card and […]
